Abstract
Composite lymphoma (CL) is a very rare clinical entity defined by the presence of two or more different subtypes of lymphoma in the same lymph node. We report a case of CL in a 78-year-old male presenting with leukocytosis and swelling of multiple lymph nodes. A left axillary node biopsy showed atypical lymphocytes in both the interfollicular and follicular areas. Immunohistochemistry revealed that mantle cell lymphoma (MCL) was mainly present in the interfollicular area and follicular lymphoma (FL) was present in the follicular area. Polymerase chain reaction analysis of immunoglobulin heavy chain gene rearrangements confirmed that they were clonally related neoplasms. However, Epstein–Barr virus (EBV) DNA was detected in only FL cells, suggesting that MCL and FL had split into two clones in the early steps of pathogenesis. This is the first reported case of CL with EBV-negative B-cell non-Hodgkin lymphoma (NHL) and EBV-positive B-cell NHL with a clonal relationship. We discuss the developmental processes of these two lymphomas.
Similar content being viewed by others
References
Suefuji N, Niino D, Arakawa F, Karube K, Kimura Y, Kiyasu J, et al. Clinicopathological analysis of a composite lymphoma containing both T- and B-cell lymphomas. Pathol Int. 2012;62:690–8.
Thirumala S, Esposito M, Fuchs A. An unusual variant of composite lymphoma: a short case report and review of the literature. Arch Pathol Lab Med. 2000;124:1376–8.
Kim H, Hendrickson R, Dorfman RF. Composite lymphoma. Cancer. 1977;40:959–76.
Küppers R, Dührsen U, Hansmann ML. Pathogenesis, diagnosis, and treatment of composite lymphomas. Lancet Oncol. 2014;15:e435–46.
Mackrides N, Campuzano-Zuluaga G, Maque-Acosta Y, Moul A, Hijazi N, Ikpatt FO, et al. Epstein-Barr virus-positive follicular lymphoma. Mod Pathol. 2017;30:519–29.
Robak T, Huang H, Jin J, Zhu J, Liu T, Samoilova O, et al., LYM-3002 Investigators. Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma. N Engl J Med. 2015; 372:944–53.
Custer R. Pitfalls in the diagnosis of lymphoma and leukemia from the pathologist’s point of view. Second National Cancer Conference; New York; 1954. 554–7.
Batinić D, Dubravcić K, Rajić L, Mikulić M, Labar B. Biphenotypic and bilineal acute leukemias. Acta Med Croatica. 2008;62:387–90.
Krikorian JG, Burke JS, Rosenberg SA, Kaplan HS. Occurrence of non-Hodgkin’s lymphoma after therapy for Hodgkin’s disease. N Engl J Med. 1979;300:452–8.
Toner GC, Sinclair RA, Sutherland RC, Schwarz MA. Composite lymphoma. Am J Clin Pathol. 1986;86:375–8.
Ho JW, Ho FC, Chan AC, Liang RH, Srivastava G. Frequent detection of Epstein-Barr virus-infected B cells in peripheral T-cell lymphomas. J Pathol. 1998;185:79–85.
Holm LE, Blomgren H, Löwhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med. 1985;312:601–4.
Guan C, Li J, Xu P, Ouyang J, Chen B. Composite primary breast diffuse large B-cell lymphoma and T lymphoblastic leukemia/lymphoma: report of a case and review of literature. Int J Clin Exp Pathol. 2015;8:9629–37.
Papathomas TG, Venizelos I, Dunphy CH, Said JW, Wang ML, Campo E, et al. Mantle cell lymphoma as a component of composite lymphoma: clinicopathologic parameters and biologic implications. Hum Pathol. 2012;43:467–80.
Fend F, Quintanilla-Martinez L, Kumar S, Beaty MW, Blum L, Sorbara L, et al. Composite low grade B-cell lymphomas with two immunophenotypically distinct cell populations are true biclonal lymphomas. A molecular analysis using laser capture microdissection. Am J Pathol. 1999;154:1857–66.
Tsang P, Pan L, Cesarman E, Tepler J, Knowles DM. A distinctive composite lymphoma consisting of clonally related mantle cell lymphoma and follicle center cell lymphoma. Hum Pathol. 1999;30:988–92.
Looi A, Gascoyne RD, Chhanabhai M, Connors JM, Rootman J, White VA. Mantle cell lymphoma in the ocular adnexal region. Ophthalmology. 2005;112:114–9.
Zamò A, Zanotti R, Lestani M, Ott G, Katzenberger T, Scarpa A, et al. Molecular characterization of composite mantle cell and follicular lymphoma. Virchows Arch. 2006;448:639–43.
Aqel N, Barker F, Patel K, Naresh KN. In-situ mantle cell lymphoma—a report of two cases. Histopathology. 2008;52:256–60.
Ilgenfritz RB, Le Tourneau A, Arborio M, Molina TJ, Diebold J, Damotte D, et al. Composite mantle cell and follicular lymphoma. A case report Hum Pathol. 2009;40:259–63.
Carbone A, Gloghini A. Coexisting follicular and mantle cell lymphoma with each having an in situ component. Am J Clin Pathol. 2011;136:481–3.
Demurtas A, Aliberti S, Bonello L, Di Celle PF, Cavaliere C, Barreca A, et al. Usefulness of multiparametric flow cytometry in detecting composite lymphoma: study of 17 cases in a 12-year period. Am J Clin Pathol. 2011;135:541–55.
Matsuoka A, Tsushima T, Tanibuchi M, Katsuki N, Kushida Y, Takata K, et al. Composite lymphoma consisting of mantle cell lymphoma and follicular lymphoma. Rinsho Ketsueki. 2013;54:2056–61.
Korać P, Horvat T, Kardum Paro MM, Ajduković R, Džebro S, Dominis M. Follicular and mantle cell lymphoma characteristics present simultaneously in the same lymph node. Appl Immunohistochem Mol Morphol. 2013;21:572–6.
Wang S, Tzankov A, Xu-Monette ZY, Hoeller S, Wang SA, Richards KL, et al. Clonally related composite follicular lymphoma and mantle cell lymphoma with clinicopathologic features and biological implications. Hum Pathol. 2013;44:2658–67.
Liu Y, Li P, Guo Y, Fan L, Wang L, Zhu J, et al. A unique composite follicular lymphoma and mantle cell lymphoma with a mixed cell pattern and aggressive course. Am J Clin Pathol. 2014;141:737–41.
Taverna J, Nair A, Yun S, Paulson S, Schatz JH, Persky D, et al. A rare presentation of in situ mantle cell lymphoma and follicular lymphoma: a case report and review of the literature. Case Rep Hematol. 2014;2014:145129.
Marí-Jimenez P, Martínez-Losada C, Centeno-Haro M, Rodríguez-García G, Perez-Seoane C, Sánchez-García J. A rare composite lymphoma: follicular and in situ mantle cell. Ann Hematol. 2016;95:1351–2.
Tennese A, Skrabek PJ, Nasr MR, Sekiguchi DR, Morales C, Brown TC, et al. Four lymphomas in 1 patient: A unique case of triple composite non-Hodgkin lymphoma followed by classical Hodgkin lymphoma. Int J Surg Pathol. 2017;25:276–80.
Subtil A, Xu Z. Follicular lymphoma with composite in situ mantle cell neoplasia. Blood. 2019;30(133):2460.
Wang Y, Xie B, Chen Y, Huang Z, Tan H. Development of angioimmunoblastic T-cell lymphoma after treatment of diffuse large B-cell lymphoma: a case report and review of literature. Int J Clin Exp Pathol. 2014;7:3432–8.
Goyal G, Nguyen AH, Kendric K, Caponetti GC. Pathol Res Pract. Composite lymphoma with diffuse large B-cell lymphoma and classical Hodgkin lymphoma components: a case report and review of the literature. 2016; 212:1179-90
Razzouk BI, Srinivas S, Sample CE, Singh V, Sixbey JW. Epstein-Barr Virus DNA recombination and loss in sporadic Burkitt’s lymphoma. J Infect Dis. 1996;173:529–35.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Norifumi Tsukamoto and Hiroshi Handa received honoraria from Kyowa Kirin, Chugai, Takeda, and Daiichi-Sankyo. Norifumi Tsukamoto received honoraria from Eisai, Pfizer, MSD, Teijin, and Astellas. Hiroshi Handa received honoraria from Celgene, Ono, Janssen, and Bayer.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Miyazawa, Y., Yokohama, A., Ishizaki, T. et al. Pathological and molecular analysis of a composite lymphoma of mantle cell lymphoma and Epstein–Barr virus-positive follicular lymphoma. Int J Hematol 113, 592–599 (2021). https://doi.org/10.1007/s12185-020-03035-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-020-03035-0